1. Home
  2. WLFC vs TVTX Comparison

WLFC vs TVTX Comparison

Compare WLFC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLFC
  • TVTX
  • Stock Information
  • Founded
  • WLFC 1985
  • TVTX 2008
  • Country
  • WLFC United States
  • TVTX United States
  • Employees
  • WLFC N/A
  • TVTX N/A
  • Industry
  • WLFC Industrial Specialties
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLFC Consumer Discretionary
  • TVTX Health Care
  • Exchange
  • WLFC Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • WLFC 1.2B
  • TVTX 1.5B
  • IPO Year
  • WLFC 1996
  • TVTX N/A
  • Fundamental
  • Price
  • WLFC $149.03
  • TVTX $21.64
  • Analyst Decision
  • WLFC
  • TVTX Strong Buy
  • Analyst Count
  • WLFC 0
  • TVTX 16
  • Target Price
  • WLFC N/A
  • TVTX $34.53
  • AVG Volume (30 Days)
  • WLFC 57.1K
  • TVTX 1.9M
  • Earning Date
  • WLFC 11-03-2025
  • TVTX 10-30-2025
  • Dividend Yield
  • WLFC 0.67%
  • TVTX N/A
  • EPS Growth
  • WLFC 30.03
  • TVTX N/A
  • EPS
  • WLFC 16.84
  • TVTX N/A
  • Revenue
  • WLFC $637,163,000.00
  • TVTX $333,865,000.00
  • Revenue This Year
  • WLFC $16.17
  • TVTX $83.26
  • Revenue Next Year
  • WLFC $4.88
  • TVTX $43.19
  • P/E Ratio
  • WLFC $8.85
  • TVTX N/A
  • Revenue Growth
  • WLFC 32.40
  • TVTX 87.94
  • 52 Week Low
  • WLFC $97.54
  • TVTX $9.44
  • 52 Week High
  • WLFC $235.43
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • WLFC 50.48
  • TVTX 78.22
  • Support Level
  • WLFC $143.39
  • TVTX $17.27
  • Resistance Level
  • WLFC $157.55
  • TVTX $19.57
  • Average True Range (ATR)
  • WLFC 4.92
  • TVTX 0.99
  • MACD
  • WLFC -0.98
  • TVTX 0.33
  • Stochastic Oscillator
  • WLFC 39.55
  • TVTX 88.44

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: